QA: Ernexa Therapeutics Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000748592_2025_Ernexa_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0000748592, Ernexa Therapeutics Inc

  xvar xval
0 AssetsCurrent 2,352,000
1 IntangibleAssetsNetIncludingGoodwill 2,044,000
2 PropertyPlantAndEquipmentNet 85,000
3 remainder_Assets 788,000
4 LiabilitiesCurrent 2,938,000
5 LiabilitiesNoncurrent 588,000
6 remainder_Liabilities 42,000
7 CostOfGoodsAndServicesSold 151,957
8 SellingGeneralAndAdministrativeExpense 13,272,955
9 ResearchAndDevelopmentExpense 4,690,611
10 remainder_Expenses -872,768
11 remainder_Revenues 675,099
12 remainder_NetIncome -23,842,518
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 5,269,000
1 Liabilities 3,568,000
2 Expenses 17,242,755
3 Revenues 675,099
4 StockholdersEquity 1,701,000
5 NetIncome -40,410,174
6 ComprehensiveNetIncome -40,410,174
7 BaseVar 25,298,686
8 EconomicCapitalRatiobeforeLimitedLiability -8.31
9 EconomicCapitalRatio 0.00565

Edgar->Model Mapping

Feature Distribution

Change over Time